Expert Guidance on Selecting Among Recommended Regimens for Rapid Initiation of First-line ART
  • CME

In this concise activity, review current evidence and gain expert insights on how to choose an optimal ART regimen for rapid start.
Gregory Huhn, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: March 25, 2020 Expiration: March 24, 2021

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Determine which patients with newly diagnosed HIV would be appropriate candidates for rapid ART initiation
  • Select optimal first-line HIV regimens when initiating rapid or same-day ART based on guideline recommendations, available evidence, and individual patient factors

Acknowledgements

Provided by USF Health

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Information on this Educational Activity

Faculty

Gregory Huhn, MD

Associate Professor
Department of Infectious Diseases
Rush University Medical Center
Attending Physician
Department of Infectious Diseases
Cook County Health
Chicago, Illinois

Gregory Huhn, MD, has disclosed that he is on the advisory board/panel for Gilead Sciences, Janssen, Theratechnologies, and ViiV Healthcare and received funds for research support from Gilead Sciences, Janssen, and ViiV Healthcare.

Staff

Tiffany Hensley-McBain, PhD

Clinical Editor

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.
Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer Blanchette, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.

USF Health OCPD staff has nothing to disclose.

Target Audience

This program is intended for physicians, pharmacists, and other healthcare providers who care for patients with HIV infection.

Goal

The goal of this activity is to improve learners’ competence in selecting appropriate regimens for rapid ART initiation in the management of patients with HIV infection.

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Physician Continuing Medical Education

Credit Designation

USF Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

USF Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program has been approved for 1.0 contact hours (0.01 CEU). Universal program number is as follows: 0230-9999-20-012-H02-P

Type of activity: Knowledge

For Pharmacists:
It is the responsibility of the pharmacy participant to ensure the provider has the learner’s birthday and e-Profile ID (ePID)/NABP number; it is the responsibility of the provider to submit to CPE Monitor participant information within 60 days of the activity for all participants who have attended, attested to their participation, and provided their ePID/NABP number and birthdate. 

ACPE indicates it is the responsibility of the pharmacy professional to confirm the status of their NABP contact hours before 60 days past the activity. If there are any discrepancies, contact the provider immediately. You may contact USF Health through cpdsupport@usf.edu.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 25, 2020, through March 24, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Week 96 analysis of ADVANCE trial comparing dolutegravir + FTC/(TAF or TDF) vs EFV/FTC/TDF from AIDS 2020: Virtual, reported by CCO

Released: July 10, 2020

Latest data from a phase I trial of capsid inhibitor lenacapavir from AIDS 2020 reported by Clinical Care Options

Released: July 10, 2020

Download CCO slides reviewing guidelines, key studies, and individual considerations for optimizing the use of current ART regimens to treat HIV

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Babafemi Taiwo, MBBS
Released: July 6, 2020

Expert CCO faculty Dr. Laura Waters outlines challenges in HIV treatment that will be discussed in an upcoming symposium at AIDS 2020: Virtual

Laura Waters, FRCP, MD Released: June 29, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?